Who
Charles J. Dockendorff
Director
Company insider
Files Form 4 as: Director, Hologic; Director, Keysight Technologies; Director, Haemonetics; Director, Boston Scientific; EVP & Chief Financial Officer, Covidien.
In numbers
- Trades disclosed
- 237
- Buys
- 5
- Sells
- 19
- Bought
- $1.8M
- Sold
- $44.0M
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 29 Jun 2007
- Last trade
- 7 Apr 2026
- Last filed
- 9 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Apr 2026filed 9 Apr 2026 | HologicMedical Devices | SEC FORM 4 Code D | —6,626 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code D | —5,535 | filing |
| 7 Apr 2026filed 9 Apr 2026 | HologicMedical Devices | SEC FORM 4 Code D | —15,370 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code D | —5,396 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —5,396 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —6,523 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —7,322 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —5,055 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —5,293 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —4,210 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —4,536 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —5,535 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code D | —6,523 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code D | —7,322 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code D | —5,055 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code D | —5,293 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code D | —4,210 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologic | SEC FORM 4 Code D | —6,626 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologic | SEC FORM 4 Code D | —15,370 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code D | —4,536 | filing |
News
Boston Scientific Corporation $BSX Stock: Goelzer Investment Management Inc. Raises PositionBSX · dailypolitical.com · 17 Oct 2026Keysight Technologies Inc RNS Announcements | 0A7N RNS AnnouncementsKEYS · investegate.co.uk · 15 Oct 2026Boston Scientific (NYSE:BSX) Upgraded at BarclaysBSX · dailypolitical.com · 10 Oct 2026Financial Contrast: Sysmex (OTCMKTS:SSMXY) and Boston Scientific (NYSE:BSX)BSX · themarketsdaily.com · 10 Oct 2026
0 headlines in the last 90 days name Charles J. Dockendorff; 4 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.